ACTIVE

KELA - Kempisch Laboratorium - Kela Laboratoria

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-1,2 M €-105,0 %over 1 year

Revenue55,2 M €+8,9 %over 1 year

Equity31,9 M €-3,6 %over 1 year

Workforce261,4 ETP+3,0 %over 1 year

Identity

Source · BCE/KBO

KELA - Kempisch Laboratorium - Kela Laboratoria is a Public limited company incorporated in 1941. Its registered office is in Hoogstraten. It employs on average 261,4 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0403.835.645
Incorporation: 15/07/1941
Legal form: Public limited company
Registered office: Sint Lenaartseweg 48
2320 Hoogstraten · FlandreSee on map
Contributed capital: 8 927 302,00 €
Latest accounts: 31/12/2025
Average workforce: 261,4 ETP

Joint committees (2)

Signals

Solid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 31 filings

Trend over 19 financial years

	2025		2024		2023		2022		2021
Income statement
Revenue	55,2 M €	+8.9%	50,7 M €	+7.8%	47 M €	-0.5%	47,2 M €	-3.3%	48,8 M €
EBITDA	1,8 M €	-57.8%	4,3 M €	+301%	1,1 M €	+703%	-177,5 k €	-104%	4,3 M €
Operating result	-746,4 k €	-133%	2,3 M €	+307%	-1,1 M €	+49.0%	-2,1 M €	-191%	2,3 M €
Net result	-1,2 M €	-105%	23,8 M €	+1160%	-2,2 M €	-289%	-575,7 k €	-148%	1,2 M €
Balance sheet
Equity	31,9 M €	-3.6%	33,1 M €	+240%	9,7 M €	-18.7%	12 M €	-6.5%	12,8 M €
Total assets	63,2 M €	+1.2%	62,4 M €	+16.3%	53,7 M €	+3.7%	51,8 M €	+3.9%	49,8 M €
Cash	1,4 M €	-82.7%	7,9 M €	+282%	2,1 M €	+116%	957,6 k €	-45.0%	1,7 M €
Debts	30,6 M €	+6.8%	28,7 M €	-34.2%	43,6 M €	+10.4%	39,5 M €	+7.1%	36,9 M €
Other
Workforce	261,4 ETP	+3.0%	253,8 ETP	+0.6%	252,3 ETP	+2.7%	245,6 ETP	-0.9%	247,8 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 35 ended

Active mandates

VOXDALE

Director · since 19 décembre 2023 · 0435.552.467

Represented by Pascal BEYENS

Active

Ended mandates

VOXDALE

Director · since 19 décembre 2023 · 0435.552.467

Represented by René BEYERS

Ended

Renatus BEYERS

Director · since 24 juin 2022 · until 19 décembre 2023

Ended

Renatus BEYERS

Director · since 24 juin 2022 · until 23 juin 2028

Ended

Philomena Van Pelt

Director · since 14 mai 2019 · until 13 mai 2025

Ended

Other companies at this address

Sint Lenaartseweg 48 2320 Hoogstraten

Company	CBE no.
KELA VETERINARIA● Active	0412.402.527
Medicem● Active	0418.885.986
PHENIX PROPERTY● Active	0413.676.987
VOXDALE● Active	0435.552.467

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	01/07/2026	30/06/2025	03/07/2024	19/07/2023	20/07/2022	19/07/2021
General meeting	02/06/2026	24/06/2025	04/06/2024	20/06/2023	24/06/2022	25/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 31 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	02/06/2026	01/07/2026	Dutch	PDF
Full model	31/12/2024	24/06/2025	30/06/2025	Dutch	PDF
Full model	31/12/2023	04/06/2024	03/07/2024	Dutch	PDF
Full model	31/12/2022	20/06/2023	19/07/2023	Dutch	PDF
Full model	31/12/2021	24/06/2022	20/07/2022	Dutch	PDF
Full model	31/12/2020	25/06/2021	19/07/2021	Dutch	PDF
Full model	31/12/2019	29/06/2020	02/07/2020	Dutch	PDF
Full model	31/12/2018	14/05/2019	04/07/2019	Dutch	PDF
Full model	31/12/2017	08/05/2018	08/06/2018	Dutch	PDF
Full model	31/12/2016	09/05/2017	01/06/2017	Dutch	PDF
Consolidated accounts	31/12/2016	09/05/2017	27/06/2017	Dutch	PDF
Full model	31/12/2015	17/05/2016	23/06/2016	Dutch	PDF
Consolidated accounts	31/12/2015	17/05/2016	17/06/2016	Dutch	PDF
Full model	31/12/2014	12/05/2015	24/06/2015	Dutch	PDF
Consolidated accounts	31/12/2014	12/05/2015	03/07/2015	Dutch	PDF
Full model	31/12/2013	13/05/2014	04/06/2014	Dutch	PDF
Consolidated accounts	31/12/2013	13/05/2014	18/06/2014	Dutch	PDF
Full model	31/12/2012	14/05/2013	16/05/2013	Dutch	PDF
Consolidated accounts	31/12/2012	14/05/2013	11/06/2013	Dutch	PDF
Full model	31/12/2011	08/05/2012	01/06/2012	Dutch	PDF
Consolidated accounts	31/12/2011	29/05/2012	28/06/2012	Dutch	PDF
Full model	31/12/2010	10/05/2011	27/05/2011	Dutch	PDF
Consolidated accounts	31/12/2010	10/05/2011	20/05/2011	Dutch	PDF
Full model	31/12/2009	11/05/2010	20/05/2010	Dutch	PDF

View all 31 filings

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 35 ended

Active mandates

VOXDALE

Director · since 19 décembre 2023 · 0435.552.467

Represented by Pascal BEYENS

Active

Ended mandates

VOXDALE

Director · since 19 décembre 2023 · 0435.552.467

Represented by René BEYERS

Ended

Renatus BEYERS

Director · since 24 juin 2022 · until 19 décembre 2023

Ended

Renatus BEYERS

Director · since 24 juin 2022 · until 23 juin 2028

Ended

Philomena Van Pelt

Director · since 14 mai 2019 · until 13 mai 2025

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates03/01/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates14/05/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates11/01/2024
DIVERSEN - DOEL - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates19/05/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates20/11/2019
ONTSLAGEN - BENOEMINGEN
PDF
Mandates25/09/2018
ONTSLAGEN - BENOEMINGEN
PDF
Mandates14/11/2017
ONTSLAGEN - BENOEMINGEN
PDF
Mandates13/02/2017
ONTSLAGEN - BENOEMINGEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 2025-1,2 M €↓
2024
Annual accounts 202423,8 M €↑
24/10/2024
nominationPascal Beyens — vast vertegenwoordiger
2023
Annual accounts 2023-2,2 M €↓
2022
Annual accounts 2022-575,7 k €↓
24/06/2022
reconductionRenatus Beyers — bestuurder
24/06/2022
nominationArnaud Clybouw — commissaris
2021
Annual accounts 20211,2 M €↑
2021
Name changeKEMPISCH LABORATORIUM
2020
Annual accounts 2020848,3 k €↑
2019
Annual accounts 201927 k €↓
2018
Annual accounts 2018376,6 k €↑
2017
Annual accounts 201761,9 k €↓
2016
Annual accounts 201670,4 k €↓
2015
Annual accounts 2015405,9 k €↓
2014
Annual accounts 2014585 k €↑
2013
Annual accounts 2013343 k €↑
2012
Annual accounts 2012199,2 k €↓
2011
Annual accounts 2011663,4 k €↓
2010
Annual accounts 20101,1 M €↑
2009
Annual accounts 2009-676,3 k €↓
2007
Annual accounts 2007325,6 k €↓
2006
Annual accounts 2006449 k €
2006
Name changeKELA - Kempisch Laboratorium - Kela Laboratoria
15/07/1941
IncorporationPublic limited company

KELA - Kempisch Laboratorium - Kela Laboratoria

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline